Bone marrow reticulin fibrosis at diagnosis in promyelocytic leukaemia treated with all-trans retinoic acid has no adverse prognosis.

Losada, Rafael; Cabrera, Humberto; Hernández, Porfirio; Hernández, Carlos; Menéndez, Aandra; Mesa, José; Plascencia, Alelí; Ramón, Luis; Agramonte, Olga; Espinosa, Edgardo

Losada, Rafael; Cabrera, Humberto; Hernández, Porfirio; Hernández, Carlos; Menéndez, Aandra; Mesa, José; Plascencia, Alelí; Ramón, Luis; Agramonte, Olga; Espinosa, Edgardo.

Affiliation

Losada R; Instituto de Hematología e Inmunología, La Habana, Cuba. ihidir@hemato.sld.cu

Acta Haematol ; 108(2): 111-2, 2002.

Article in En | MEDLINE | ID: mdl-12187033

Subject(s)

Leukemia, Promyelocytic, Acute/complications; Leukemia, Promyelocytic, Acute/drug therapy; Primary Myelofibrosis/etiology; Tretinoin/administration & dosage; Adolescent; Adult; Aged; Child; Child, Preschool; Humans; Leukemia, Promyelocytic, Acute/pathology; Middle Aged; Primary Myelofibrosis/diagnosis; Prognosis; Reticulin; Tretinoin/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tretinoin / Leukemia, Promyelocytic, Acute / Primary Myelofibrosis Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged Language: En Journal: Acta Haematol Year: 2002 Document type: Article Affiliation country: Cuba

Search on Google

Add to My VHL

XML

PubMed Links